Stock Earnings Analyzing Mersana Therapeutics Inc (MRSN) After Recent Trading Activity Mersana Therapeutics Inc’s recent filing unveils that its VP, Chief Accounting Officer Mandelia Ashish unloaded Company’s shares for reported $2061.0
Insiders Updates Mersana Therapeutics Inc [MRSN] Investment Appeal on the Rise In a filing, Mersana Therapeutics Inc revealed its VP, Chief Accounting Officer Mandelia Ashish unloaded Company’s shares for reported $2061.0
Stock Earnings An Analysis of Mersana Therapeutics Inc (MRSN)’s Potential Price Growth Mersana Therapeutics Inc’s filing revealed that its VP, Chief Accounting Officer Mandelia Ashish unloaded Company’s shares for reported $2061.0 on